Changes in Beneficial Ownership · 4
Regencell Bioscience Holdings Limited
RGCNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
ownership.xml
Filing details
- Report period
- 2026-05-27
- Issuer
- Regencell Bioscience Holdings Ltd
- Issuer CIK
- 0001829667
- Trading symbol
- RGC
Reporting owner 1
- Name
- LO WILLIAM WING YAN DR
- Reporting owner CIK
- 0001134441
- Relationship
- Director
- Address
- C/O 9/F CHINACHEM LEIGHTON PLAZA, 29 LEIGHTON ROAD, CAUSEWAY BAY, HONG KONG, CHINA, F4
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to purchase) | 0.84[F1] | 2026-05-27 | D · Form 4 | 70,600 | D | [F2] | [F2] | [F2] | Ordinary shares, par value $0.00001 | 70,600 | 521,630 | D |
Table key
- D · Form 4
- Disposition to the issuer under Rule 16b-3(e)
- D
- Direct
Footnotes
- F1
- The exercise price has given effect to the share split(s) of the Issuer since the date of grant of the option.↩ 1
- F2
- On May 27, 2026, the Issuer repurchased from the Reporting Person options to purchase 70,600 ordinary shares of the Issuer at a price of $15.00 per option. The aggregate consideration payable to the Reporting Person under the Option Repurchase Agreement is further reduced by the aggregate exercise price of the repurchased options.↩ 1↩ 2↩ 3
Signature 1
- Signed
- /s/ James Wai Hong Chung, attorney-in-fact
- Date
- 2026-05-29
Company context
We are an early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. Our goal is to save and improve the lives of the patients, their families and caregivers and become a market leader for natural and holistic treatments for neurological disorders globally.